This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anna, C. H. Articles by Devereux, T. R. Search for Related Content PubMed PubMed Citation Articles by Anna, C. H. Articles by Devereux, T. R.

ß-Catenin Mutations and Protein Accumulation in All Hepatoblastomas Examined from B6C3F1 Mice Treated with Anthraquinone or Oxazepam

Laboratories of Molecular Carcinogenesis [C. H. A., T. R. D.] and Experimental Pathology [R. C. S., J. F. F., P. S. S., T-V. T.], National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709

The molecular pathogenesis of hepatoblastomas in the B6C3F1 mouse is unclear but may involve alterations in the ß-catenin/Wnt signaling pathway as was recently described for chemically induced hepatocellular neoplasms and human liver cancers. The objective of this study was to characterize the mutation frequency and spectrum of ß-catenin mutations and the intracellular localization of ß-catenin protein accumulation in chemically induced hepatoblastomas. In this study, ß-catenin mutations were identified in all 19 anthraquinone-induced hepatoblastomas and all 8 oxazepam-induced hepatoblastomas examined. Although several hepatoblastomas had multiple deletion and/or point mutations, the pattern of mutations in the hepatoblastomas did not differ from that identified in hepatocellular neoplasms. In a majority of the hepatoblastomas (six of seven) examined by immunohistochemical methods, both nuclear and cytoplasmic localization of ß-catenin protein were detected, whereas in hepatocellular adenomas, carcinomas, and normal liver only membrane staining was observed. Our data suggest that ß-catenin mutations and the subsequent translocation of ß-catenin protein from the cell membrane to the cytoplasm and nucleus may be critical steps in providing hepatocellular proliferative lesions with the growth advantage to progress to hepatoblastomas.

This article has been cited by other articles:

				M. Kushida, S. Aiso, K. Morimura, M. Wei, H. Wanibuchi, K. Nagano, and S. Fukushima Absence of {beta}-Catenin Alteration in Hepatic Tumors Induced by p-Nitroanisole in Crj:BDF1 Mice Toxicol Pathol, April 1, 2006; 34(3): 237 - 242. [Abstract] [Full Text] [PDF]

				M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors Toxicol. Sci., April 1, 2006; 90(2): 400 - 418. [Abstract] [Full Text] [PDF]

				M. Iida, C. H. Anna, W. M. Holliday, J. B. Collins, M. L. Cunningham, R. C. Sills, and T. R. Devereux Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens Carcinogenesis, March 1, 2005; 26(3): 689 - 699. [Abstract] [Full Text] [PDF]

				Y. Kim, R. C. Sills, and C. D. Houle Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse Liver Toxicol Pathol, January 1, 2005; 33(1): 175 - 180. [Abstract] [Full Text] [PDF]

				R.C. Sills, H.L. Hong, G. Flake, C. Moomaw, N. Clayton, G.A. Boorman, J. Dunnick, and T.R. Devereux o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis Carcinogenesis, April 1, 2004; 25(4): 605 - 612. [Abstract] [Full Text] [PDF]

				R.R. Maronpot, G. Flake, and A. J. Huff Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention Toxicol Pathol, January 1, 2004; 32(1_suppl): 40 - 48. [Abstract] [PDF]

				M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643 Carcinogenesis, April 1, 2003; 24(4): 757 - 770. [Abstract] [Full Text] [PDF]

				J. Gotoh, M. Obata, M. Yoshie, S. Kasai, and K. Ogawa Cyclin D1 over-expression correlates with {beta}-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3{beta} and ERK1/2 in mouse hepatic carcinogenesis Carcinogenesis, March 1, 2003; 24(3): 435 - 442. [Abstract] [Full Text] [PDF]

				V. S. Turusov, M. Tor, R. C. Sills, G. A. Willson, R. A. Herbert, J. R. Hailey, J. K. Haseman, and G. A. Boorman Hepatoblastomas in Mice in the US National Toxicology Program (NTP) Studies Toxicol Pathol, August 1, 2002; 30(5): 580 - 591. [Abstract] [PDF]

				M. Suzui, M. Masuda, J. T. E. Lim, C. Albanese, R. G. Pestell, and I. B. Weinstein Growth Inhibition of Human Hepatoma Cells by Acyclic Retinoid Is Associated with Induction of p21CIP1 and Inhibition of Expression of Cyclin D1 Cancer Res., July 15, 2002; 62(14): 3997 - 4006. [Abstract] [Full Text] [PDF]

				N. Harada, H. Miyoshi, N. Murai, H. Oshima, Y. Tamai, M. Oshima, and M. M. Taketo Lack of Tumorigenesis in the Mouse Liver after Adenovirus-mediated Expression of a Dominant Stable Mutant of {beta}-Catenin Cancer Res., April 1, 2002; 62(7): 1971 - 1977. [Abstract] [Full Text] [PDF]

				L. C. Pulling, D. M. Klinge, and S. A. Belinsky p16INK4a and {beta}-catenin alterations in rat liver tumors induced by NNK Carcinogenesis, March 1, 2001; 22(3): 461 - 466. [Abstract] [Full Text] [PDF]

				D. F. Calvisi, V. M. Factor, R. Loi, and S. S. Thorgeirsson Activation of {beta}-Catenin during Hepatocarcinogenesis in Transgenic Mouse Models: Relationship to Phenotype and Tumor Grade Cancer Res., March 1, 2001; 61(5): 2085 - 2091. [Abstract] [Full Text]

				S. C. Abraham, B. Nobukawa, F. M. Giardiello, S. R. Hamilton, and T.-T. Wu Sporadic Fundic Gland Polyps : Common Gastric Polyps Arising Through Activating Mutations in the {beta}-Catenin Gene Am. J. Pathol., March 1, 2001; 158(3): 1005 - 1010. [Abstract] [Full Text] [PDF]